Ashfield Pharmacovigilance, part of UDG Healthcare, is proud to be partnering with Allan Lloyds at the Risk Management and Pharmacovigilance America Summit 2016, which will take place October 18-20 2016 in Boston, Massachusetts. This two day event will bring together leading pharmacovigilance experts.
In addition to their Silver Sponsorship, Ashfield Pharmacovigilance’s Sharon Donatucci will be presenting on solicited report challenges. This session will address the challenge of handling incomplete data from reporters, the challenge of obtaining follow-up from patients, and the impact on the safety profile of the drug. Other featured hot topics will include: the future of pharmacovigilance and the impact of artificial Intelligence, globalization of pharmacovigilance and integration of databases, the current pharmacovigilance processes in the US, Europe and Latin America and how to use evidence from big data to assess potential safety concerns during pre-approval.
You can learn more about Allan Lloyds at the Risk Management and Pharmacovigilance America Summit 2016 and register here.